World Intellectual Property Organization

PCT Notable Inventions: Anti-HIV Vaccine

The Kenya AIDS Vaccine Initiative (KAVI) at the University of Nairobi has attracted world attention through the development of a pair of candidate vaccines aimed at preventing HIV infection and AIDS, in partnership with scientists from the UK Medical Research Council's Human Immunology Unit at the University of Oxford and the International AIDS Vaccine Initiative (IAVI).

Anti-HIV Vaccine
PCT Application: (WO 01/47955) Improvements in or relating to Immune Responses to HIV
Selection of references: Case Study: Anti-HIV vaccine developed in Kenya Adobe PDF
WIPO Magazine, September/October 2003
Links: International Aids Vaccine Initiative
Medical Research Council

Explore WIPO